T he use of new molecular diagnostic technique for detection of parathyroid cancer is very interesting (1) . The new molecular approach is expected to be the effective biomarker tool for using as tumor marker. In Thailand, the new diagnostic tool has just been introduced for a few years. In a recent report, Niramitmahapanya et al mentioned that "HRPT2 mutations by SyBr Green PCR sensitive technique to identify parathyroid cancers or atypical adenoma from benign parathyroid tissue (2) . " Here, the authors performed a cost analysis on the available for somatic and germline SyBr Green PCR method screening for parathyroid gland; a cost analysis in Thailand. The cost is referred to the data from tertiary referencing center in Bangkok, Thailand. The utility is according to the previous report by Niramitmahapanya et al, on using for somatic and germline SyBr Green PCR method screening for parathyroid gland in the tertiary referencing center in Bangkok (Rajvithi hospital), Thailand (2). According to this study, the cost and utility of somatic and germline SyBr Green PCR method screening for parathyroid gland is shown in Table 1 . According to the cost analysis, the cost utility for using the new technique is still high and might DOI: 10.15171/jpd.2018.11
Implication for health policy/practice/research/ medical education
The cost and utility of somatic and germline SyBr Green PCR method screening for parathyroid gland is discussed in this paper. According to the cost analysis, the cost utility for using the new technique is still high and might be a problem for future implementation of the technique in Thailand. be a problem for future implementation of the technique in Thailand.
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